Immune · Immune peptide (research)
KPV
- Drug class
- Immune peptide (research)
- Status
- Compounded (503A)
- Also known as
- lys-pro-val, alpha-msh fragment, kpv peptide
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What KPV is studied for
- Anti-inflammatory (research)
- Gut healing (research)
- Skin support (research)
Mechanism of action
KPV is being studied in the immune category. Anti-inflammatory tripeptide from α-MSH — studied for gut and skin. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is KPV?
KPV is a immune peptide. Anti-inflammatory tripeptide from α-MSH — studied for gut and skin.
What is KPV studied for?
Published research has examined KPV for anti-inflammatory, gut healing, skin support. Human clinical evidence varies by indication.
Is KPV FDA-approved?
No. KPV is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is KPV used in research?
Protocols vary by study. KPV is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for KPV is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.